Patients With Pretreated SCLC Have Improved Outcomes When Apatinib is Added to ChemoJanuary 30th 2021
Updated data from a phase 2 trial of apatinib added to single-agent chemotherapy for small cell lung cancer in patients with prior treatments indicate a good efficacy and safety for the combination.
Oral Paclitaxel, Encequidar Combo Associated with Improved Efficacy, Lower Neuropathy Rates in mBCDecember 10th 2020
Treatment with the combination of oral paclitaxel and encequidar was found to be associated with greater efficacy in patients with metastatic breast cancer, as well as lower rates of chemotherapy-induced peripheral neuropathy, compared to intravenous paclitaxel.
Carfilzomib Triplet Fails to Induce Superior PFS in Newly Diagnosed Multiple MyelomaMay 29th 2020
Carfilzomib combined with lenalidomide and dexamethasone failed to improve progression-free survival, compared with the current standard of care triplet of bortezomib, lenalidomide, and dexamethasone, in patients with newly diagnosed multiple myeloma.
Study Finds Increased Risk for Death Following Chemo Use in Patients with Thoracic Cancer, COVID-19May 28th 2020
Chemotherapy use in patients with lung and other thoracic cancers who are also diagnosed with COVID-19 was found to be associated with an increased risk of death compared to other treatment methods.